Related references
Note: Only part of the references are listed.Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro
Jin Wen et al.
CANCER CELL INTERNATIONAL (2015)
Emerging therapeutic targets in bladder cancer
Benedito A. Carneiro et al.
CANCER TREATMENT REVIEWS (2015)
Targeting the androgen receptor in prostate and breast cancer: several new agents in development
Tracy Proverbs-Singh et al.
ENDOCRINE-RELATED CANCER (2015)
Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population
Koichi Matsuda et al.
HUMAN MOLECULAR GENETICS (2015)
Androgen receptor immunohistochemistry in genitourinary neoplasms
Elizabeth M. Williams et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2015)
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A. Knowles et al.
NATURE REVIEWS CANCER (2015)
Evaluation of Contemporary Prostate and Urothelial Lineage Biomarkers in a Consecutive Cohort of Poorly Differentiated Bladder Neck Carcinomas
Sambit K. Mohanty et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition
W. Jitao et al.
ANDROLOGIA (2014)
Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian study
Nariman Ahmadi et al.
ANZ JOURNAL OF SURGERY (2014)
Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition
Yifeng Jing et al.
CANCER LETTERS (2014)
Testosterone Changes Bladder and Kidney Structure in Juvenile Male Rats
Linda M. Dairiki Shortliffe et al.
JOURNAL OF UROLOGY (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver
C. Chang et al.
ONCOGENE (2014)
Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5
Taewan Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer
Jie Luo et al.
TUMOR BIOLOGY (2014)
Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians
Vibha Singh et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis
Baoming Ren et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Androgen deprivation therapy prevents bladder cancer recurrence
Koji Izumi et al.
ONCOTARGET (2014)
Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor
Jong-Wei Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Constitutive β-Catenin Activation Induces Male-Specific Tumorigenesis in the Bladder Urothelium
Congxing Lin et al.
CANCER RESEARCH (2013)
Androgen activates β-catenin signaling in bladder cancer cells
Yi Li et al.
ENDOCRINE-RELATED CANCER (2013)
Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1
Stella Koutros et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
Michael A. Augello et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma: Comprehensive Analysis of 1,476 Radical Cystoprostatectomy Specimens
Harman Maxim Bruins et al.
JOURNAL OF UROLOGY (2013)
Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen-induced bladder carcinogenesis
Koji Izumi et al.
MOLECULAR CARCINOGENESIS (2013)
Epidermal growth factor enhances androgen receptor-mediated bladder cancer progression and invasion via potentiation of AR transactivation
Teng-Fu Hsieh et al.
ONCOLOGY REPORTS (2013)
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
Lina Gao et al.
PLOS ONE (2013)
Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity
Georgios Gakis et al.
WORLD JOURNAL OF UROLOGY (2013)
On the Origins of the Androgen Receptor Low Molecular Weight Species
Maria Mudryj et al.
HORMONES & CANCER (2013)
Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series
Pierre Nevoux et al.
BJU INTERNATIONAL (2012)
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
Hiroshi Miyamoto et al.
BJU INTERNATIONAL (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
The androgen receptor and stem cell pathways in prostate and bladder cancers (Review)
Katarzyna Marcinkiewicz et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor
Koji Izumi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens
M. Alsinnawi et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
Masaki Shiota et al.
JOURNAL OF UROLOGY (2012)
Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk
Yi-Ping Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated
Jonathan B. Overdevest et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens
H. M. Fritsche et al.
VIRCHOWS ARCHIV (2012)
Androgen receptor co-activators in the regulation of cellular events in prostate cancer
Zoran Culig et al.
WORLD JOURNAL OF UROLOGY (2012)
Recent Advances in Treatment of Advanced Urothelial Carcinoma
Jenny J. Kim
CURRENT UROLOGY REPORTS (2012)
The 8q24 Gene Desert: An Oasis of Non-Coding Transcriptional Activity
Konrad Huppi et al.
Frontiers in Genetics (2012)
Genetic variants in urinary bladder cancer: collective power of the wimp SNPs
Klaus Golka et al.
ARCHIVES OF TOXICOLOGY (2011)
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study
Carmen Mir et al.
BJU INTERNATIONAL (2011)
Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells
Yichun Zheng et al.
ENDOCRINE-RELATED CANCER (2011)
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3
Montserrat Garcia-Closas et al.
HUMAN MOLECULAR GENETICS (2011)
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene
Thorunn Rafnar et al.
HUMAN MOLECULAR GENETICS (2011)
Role of Androgen Receptor and Associated Lysine-Demethylase Coregulators, LSD1 and JMJD2A, in Localized and Advanced Human Bladder Cancer
Eric C. Kauffman et al.
MOLECULAR CARCINOGENESIS (2011)
Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
Kristin R. Lamont et al.
MOLECULAR ENDOCRINOLOGY (2011)
Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression
Can Tuygun et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): Mechanisms responsible for interindividual variation of UGT levels
Karl Walter Bock
BIOCHEMICAL PHARMACOLOGY (2010)
Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer
Ji-Tao Wu et al.
UROLOGY (2010)
Progression of prostate cancer: Multiple pathways to androgen independence
Hong-Lin Devlin et al.
CANCER LETTERS (2009)
Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population
Meilin Wang et al.
CARCINOGENESIS (2009)
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
Stephen A. Boorjian et al.
ENDOCRINE-RELATED CANCER (2009)
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
Xifeng Wu et al.
NATURE GENETICS (2009)
Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines
Akiko Nakamura et al.
DRUG METABOLISM AND DISPOSITION (2008)
Temporal-spatial protein expression in bladder tissue derived from embryonic stem cells
John C. Thomas et al.
JOURNAL OF UROLOGY (2008)
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Lambertus A. Kiemeney et al.
NATURE GENETICS (2008)
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1
Aimee M Johnson et al.
BMC Urology (2008)
Promotion of bladder cancer development and progression by androgen receptor signals
Hiroshi Miyamoto et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Experimental models of human bladder carcinogenesis
RA Crallan et al.
CARCINOGENESIS (2006)
Androgjen receptor expression is inversely correlated with pathologic, tumor stage in bladder cancer
S Boorjian et al.
UROLOGY (2004)
Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines
FH Chen et al.
JOURNAL OF UROLOGY (2003)
Thrombospondins 1 and 2 function as inhibitors of angiogenesis
LC Armstrong et al.
MATRIX BIOLOGY (2003)
Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity
CS Higano
UROLOGY (2003)
Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene
A Jain et al.
MOLECULAR ENDOCRINOLOGY (2002)
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP
W Zhu et al.
CARCINOGENESIS (2001)
Co-localization of androgen receptor with estrogen receptor β in the lower urinary tract of the male rat
S Salmi et al.
JOURNAL OF UROLOGY (2001)
The effects of organ resection on rat urinary bladder carcinogenesis
S Saikawa et al.
UROLOGICAL RESEARCH (2001)
Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the α5β1 fibronectin receptor
GJ Zhang et al.
JOURNAL OF UROLOGY (2000)